Show notes
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com
On today’s debut interview with Truvian Health, CEO Jay Srinivasan lays out the company’s bold but grounded plan to radically decentralize blood testing. With over $150 million raised and a benchtop instrument already in FDA review, Truvian aims to run 34 lab-quality tests from just eight drops of blood—in under 30 minutes.
“Why does your blood have to t…
